CureVac NV (CVAC)
3.49
+0.01
(+0.29%)
USD |
NASDAQ |
May 17, 16:00
3.49
0.00 (0.00%)
After-Hours: 20:00
CureVac Free Cash Flow (Quarterly): -61.17M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -61.17M |
September 30, 2023 | -80.26M |
June 30, 2023 | -87.26M |
March 31, 2023 | -121.10M |
December 31, 2022 | -88.18M |
September 30, 2022 | -50.02M |
June 30, 2022 | -89.45M |
March 31, 2022 | -172.47M |
December 31, 2021 | -260.19M |
September 30, 2021 | -338.42M |
Date | Value |
---|---|
June 30, 2021 | -139.52M |
March 31, 2021 | -280.62M |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | -8.769M |
December 31, 2019 | |
September 30, 2019 | |
March 31, 2019 | -28.26M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-338.42M
Minimum
Sep 2021
-8.769M
Maximum
Mar 2020
-136.72M
Average
-89.45M
Median
Jun 2022
Free Cash Flow (Quarterly) Benchmarks
Affimed NV | -27.55M |
InflaRx NV | -16.17M |
MorphoSys AG | -- |
BioNTech SE | -493.35M |
Immatics NV | -45.38M |